Global X Adaptive U.S. Factor ETF (AUSF) is an exchange-traded fund that provides investors with dynamic exposure to U.S. large- and mid-cap equities through a multi-factor strategy emphasizing minimum volatility, value, and momentum factors; the fund tracks the Adaptive Wealth Strategies U.S. Factor Index, which was developed by NorthCrest Asset Management and calculated by Solactive AG. AUSF dynamically allocates across three sub-portfolios, holding the two weakest-performing factors over the trailing two-year period at 50% weight each or all three factors (40%/40%/20%) when performance differences among the top two are within 2%; this approach seeks to outperform traditional market-cap weighted indexes by capitalizing on factor mean-reversion while maintaining tax efficiency relative to individual factor ETFs. The fund's portfolio features approximately 100 stocks per factor sub-portfolio, with top holdings including Royalty Pharma Plc, Verizon Communications Inc., AT&T Inc., Amdocs Ltd., and Cisco Systems Inc., and sector weights led by financials (23.2%), industrials (12.9%), and health care (11.6%) .
Launched on August 24, 2018, and listed on NYSE Arca, AUSF is issued and managed by Global X Management Company LLC, a subsidiary of Mirae Asset Global Investments (Group), which is headquartered in New York with primary operations focused on the U.S. equity market and institutional and retail investors seeking factor-based strategies. In recent developments, institutional investors such as IFP Advisors Inc., Synergy Investment Management LLC, Larson Financial Group LLC, and Janney Montgomery Scott LLC have initiated or expanded positions in AUSF during 2025, reflecting growing interest amid the fund's net assets reaching approximately $739 million and a year-to-date total return of 14.31% as of late 2025. Global X, under Mirae Asset, continues to expand its broader ETF lineup with thematic launches like AI ecosystem products and a U.S. natural gas ETF in 2025, though AUSF maintains its core focus on adaptive U.S. factor rotation without specific product alterations.